Alessandra Cancellieri

Suggest Changes
Learn More
PURPOSE In non-small-cell lung cancer (NSCLC), clinical and biologic predictors for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor sensitivity have been identified in retrospective(More)